Published in Arch Pathol on August 01, 1974
Ischemic tissue injury. Am J Pathol (1975) 2.29
Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol (1992) 1.80
Prevention by chlorpromazine of ischemic liver cell death. Am J Pathol (1977) 1.31
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression. J Am Soc Nephrol (2015) 1.30
Acute renal failure. Lessons from pathophysiology. West J Med (1992) 1.15
Mannitol. West J Med (1979) 0.95
Glomerular mesangial and endothelial cell swelling following temporary renal ischemia and its role in the no-reflow phenomenon. Am J Pathol (1977) 0.81
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation (1977) 5.67
The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest (1974) 4.42
The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest (1979) 3.87
Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst (1998) 3.17
Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol (1974) 3.09
Ischemic injury of myocardium. Ann N Y Acad Sci (1969) 2.87
Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol (1972) 2.87
Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol (1974) 2.71
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res (2001) 2.50
Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res (1990) 2.45
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Ann Oncol (2007) 2.43
Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest (1986) 2.42
Structural changes in myocardium during acute ischemia. Circ Res (1974) 2.36
Kinetics of calcium accumulation in acute myocardial ischemic injury. Am J Pathol (1972) 2.34
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol (2002) 2.33
Ischemic tissue injury. Am J Pathol (1975) 2.29
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol (2008) 2.29
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients. Ann Oncol (2007) 2.11
Structural and functional abnormalities in mitochondria isolated from ischemic dog myocardium. Lab Invest (1969) 2.07
Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation (2001) 2.06
Ultrastructural studies of vasopressin effect on isolated perfused renal collecting tubules of the rabbit. J Cell Biol (1968) 2.06
Lethal myocardial ischemic injury. Am J Pathol (1981) 2.05
Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res (2000) 1.98
Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol (1978) 1.84
Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res (1985) 1.83
Alkaline lability of fluorescent photoproducts produced in ultraviolet light-irradiated DNA. J Biol Chem (1982) 1.79
Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation (2001) 1.77
IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol (1982) 1.73
Early phase of myocardial ischemic injury and infarction. Am J Cardiol (1969) 1.70
Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res (1973) 1.65
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy. Ann Oncol (2006) 1.60
Irreversible myocardial injury in anoxic perfused rat hearts. Am J Pathol (1975) 1.60
Paths of transtubular water flow in isolated renal collecting tubules. J Cell Biol (1969) 1.57
Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis (2000) 1.52
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst (2001) 1.45
Fine structural and biochemical changes in dog myocardium during autolysis. Am J Pathol (1969) 1.43
Escherichia coli DNA photolyase reverses cyclobutane pyrimidine dimers but not pyrimidine-pyrimidone (6-4) photoproducts. J Biol Chem (1985) 1.43
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer (1997) 1.42
Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone. Hum Pathol (1994) 1.41
Contraction band necrosis and irreversible myocardial injury. J Mol Cell Cardiol (1983) 1.41
Uracil-DNA glycosylase in the extreme thermophile Archaeoglobus fulgidus. J Biol Chem (2000) 1.40
Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res (1985) 1.39
Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol (1981) 1.37
Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol (1978) 1.37
Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer (1987) 1.34
Structural determination of the ultraviolet light-induced thymine-cytosine pyrimidine-pyrimidone (6-4) photoproduct. Nucleic Acids Res (1985) 1.34
Nucleotide metabolism and cellular damage in myocardial ischemia. Annu Rev Physiol (1985) 1.33
Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest (1992) 1.33
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene (2012) 1.33
Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol (1989) 1.33
Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion. J Mol Cell Cardiol (1986) 1.32
Deletion of the p53 gene in a patient with aggressive burn scar carcinoma. J Trauma (1997) 1.31
Thermostable uracil-DNA glycosylase from Thermotoga maritima a member of a novel class of DNA repair enzymes. Curr Biol (1999) 1.30
Light and electron microscopic studies of pigment in human and rhesus monkey substantia nigra and locus coeruleus. Anat Rec (1966) 1.28
Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts. Am J Pathol (1976) 1.28
Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors. Clin Cancer Res (1998) 1.27
Distribution of coronary collateral flow in acute myocardial ischaemic injury: effect of propranolol. Cardiovasc Res (1976) 1.26
Alterations in renal cortex following ischemic injury. 3. Ultrastructure of proximal tubules after ischemia or autolysis. Lab Invest (1972) 1.26
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol (1994) 1.26
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib. Ann Oncol (2006) 1.25
Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs. Circulation (1977) 1.24
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. Ann Oncol (2009) 1.24
Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res (1994) 1.24
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer (2007) 1.24
Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol (1986) 1.23
Removal of UV light-induced pyrimidine-pyrimidone(6-4) products from Escherichia coli DNA requires the uvrA, uvrB, and urvC gene products. Proc Natl Acad Sci U S A (1984) 1.22
Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol (1990) 1.20
Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res (1996) 1.19
Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol (1985) 1.17
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia (1989) 1.16
Electrolytes of damaged myocardial mitochondria. Proc Soc Exp Biol Med (1970) 1.16
In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit. Mol Cell Probes (1990) 1.15
Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. Br J Cancer (2002) 1.15
Protein-protein interactions between the Escherichia coli single-stranded DNA-binding protein and exonuclease I. Radiat Res (1996) 1.15
Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. Clin Cancer Res (2001) 1.14
The folate-binding protein of rat kidney. Purification, properties, and cellular distribution. J Biol Chem (1984) 1.13
Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation (1985) 1.13
Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. Circ Res (1985) 1.12
DNA deoxyribophosphodiesterase of Escherichia coli is associated with exonuclease I. Nucleic Acids Res (1992) 1.10
The role of the (6-4) photoproduct in ultraviolet light-induced transition mutations in E. coli. Mutat Res (1986) 1.08
Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc Res (1994) 1.08
DNA deoxyribophosphodiesterase and an activity that cleaves DNA containing thymine glycol adducts in Deinococcus radiodurans. Radiat Res (1994) 1.08
Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart. Circ Res (1987) 1.08
Purification and characterization of Thermotoga maritima endonuclease IV, a thermostable apurinic/apyrimidinic endonuclease and 3'-repair diesterase. J Bacteriol (1999) 1.07
Nephrotic syndrome in pregnancy. Clinical, histologic and fine structural studies. Am J Obstet Gynecol (1973) 1.07
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients. Br J Cancer (2005) 1.06
Heat shock protein 70 binds to human apurinic/apyrimidinic endonuclease and stimulates endonuclease activity at abasic sites. J Biol Chem (2000) 1.06
The pathogenesis of drug-induced renal cystic disease. Kidney Int (1974) 1.05
Light and dark cells as artifacts of liver fixation. Lab Invest (1968) 1.05
Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood. Circulation (1983) 1.05